It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2018.
2018 | Mumbai, Maharashtra, India | ActiveJwell Pharmaceuticals Private Limited, a active private limited company, was established on 22 February 2018 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999MH2018PTC305381. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹50.00 K .
Its leadership includes Sherol Castelino (Director), Hitesh Nandlal Waghela (Director), Mohammed Altaf Shaikh (Director). Past directors included Sherol Castelino, Meeta Hitesh Waghela, Hitesh Nandlal Waghela. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Shop No.7, Kadri House, Chimatpada, Marol Naka, J.B. Nagar, Andheri Kurla Road, Andheri, East,, Mumbai, Maharashtra, 400059.
U74999MH2018PTC305381
305381
22 February 2018
₹1.00 M
₹50.00 K
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Jwell Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sherol Castelino | Director | 21 Jan 2021 | Current |
| Hitesh Nandlal Waghela | Director | 01 Jan 2021 | Current |
| Mohammed Altaf Shaikh | Director | 01 Jan 2021 | Current |
| Harsh Sanjeev Poojary | Director | 25 Jan 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Director | 18 Sep 2020 | Past |
| Pramod Abcsdd | Director | 18 Sep 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Jwell Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1017.86% increase. The company also saw a substantial fall in profitability, with a 1631.38% decrease in profit. The company's net worth observed a substantial decline by a decrease of 840.76%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Jwell Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Jwell Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Jwell Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jwell Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Harsh Sanjeev Poojary was appointed as a Director was appointed as a Director on 25 Jan 2024 & has been associated with this company since 1 year 10 months . was documented.
The activity Jwell Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.
Progress on Jwell Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was documented.
Sherol Castelino was appointed as a Director was appointed as a Director on 21 Jan 2021 & has been associated with this company since 4 years 10 months . was recorded as a recent event.
Hitesh Nandlal Waghela was appointed as a Director was appointed as a Director on 01 Jan 2021 & has been associated with this company since 4 years 11 months . was recorded as a recent event.
Progress on Mohammed Altaf Shaikh was appointed as a Director was appointed as a Director on 01 Jan 2021 & has been associated with this company since 4 years 11 months . was documented.
The CIN of Jwell Pharmaceuticals Private Limited is U74999MH2018PTC305381.
Jwell Pharmaceuticals Private Limited is headquartered at Shop No.7, Kadri House, Chimatpada, Marol Naka, J.B. Nagar, Andheri Kurla Road, Andheri, East,, Mumbai, Maharashtra, 400059.
Jwell Pharmaceuticals Private Limited was incorporated on 22 February 2018.
The current directors of Jwell Pharmaceuticals Private Limited are
The primary industry of Jwell Pharmaceuticals Private Limited is Trade.
Jwell Pharmaceuticals Private Limited is unlisted.
The authorized capital of Jwell Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹50.00 K .
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX